| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT07290036 A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly… |
Trial sites expanded: 57 -> 61 locations |
| 2026-06-06 | NCT07219420 A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With… |
Trial sites expanded: 41 -> 74 locations |
| 2026-06-02 | NCT04009499 A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the… |
Trial completed |
| 2026-05-30 | NCT04976322 A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study… |
Trial sites expanded: 106 -> 109 locations |
| 2026-05-23 | NCT07290036 A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly… |
Trial sites expanded: 52 -> 57 locations |
| 2026-05-23 | NCT07277660 A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and… |
Trial sites expanded: 57 -> 62 locations |
| 2026-05-23 | NCT05063162 A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With… |
Trial sites reduced: 73 -> 55 locations |
| 2026-05-21 | NCT06506916 A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-20 | NCT05077904 A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12… |
date change Primary completion pushed: 2026-04 -> 2026-06-30 |
| 2026-05-20 | NCT05077904 A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12… |
date change Completion pushed: 2026-04 -> 2026-06-30 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07246564 | Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese… | Myasthenia Gravis | Recruiting |
| Phase 3 | |||
| NCT06315322 | A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study… | Childhood Absence Epilepsy | Recruiting |
| NCT05077904 | A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12… | Stereotypical Prolonged Seizures | Recruiting |
| NCT06425549 | A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in… | Moderate to Severe Plaque Psoriasis | Recruiting |
| NCT06617325 | A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants… | Systemic Lupus Erythematosus | Recruiting |
| NCT06668181 | An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in… | Enthesitis-related Arthritis | Recruiting |
| NCT06921850 | A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and… | Hidradenitis Suppurativa | Recruiting |
| NCT07219420 | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With… | Palmoplantar Pustulosis | Recruiting |
| NCT07465289 | A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult… | Ocular Myasthenia Gravis | Not Yet Recruiting |
| NCT04666610 | A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy… | Childhood Absence Epilepsy | Active, Not Recruiting |
| NCT07463521 | A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With… | Ocular Myasthenia Gravis | Not Yet Recruiting |
| NCT04123795 | A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol… | Moderate Chronic Plaque Psoriasis | Active, Not Recruiting |
| NCT04225871 | Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis | Generalized Myasthenia Gravis | Active, Not Recruiting |
| NCT05076617 | A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants… | Stereotypical Prolonged Seizures | Enrolling by Invitation |
| NCT06435312 | An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric… | Generalized Myasthenia Gravis | Enrolling by Invitation |
| NCT06540144 | An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric… | Generalized Myasthenia Gravis | Enrolling by Invitation |
| NCT06506916 | A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study… | Moderate to Severe Plaque Psoriasis | Active, Not Recruiting |
| NCT04436640 | A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in… | Axial Spondyloarthritis | Active, Not Recruiting |
| NCT05063162 | A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With… | Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD) | Active, Not Recruiting |
| NCT04976322 | A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study… | Systemic Lupus Erythematosus | Enrolling by Invitation |
| NCT04901195 | A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With… | Hidradenitis Suppurativa | Active, Not Recruiting |
| NCT06624228 | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants… | Psoriatic Arthritis | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT06055959 | A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized… | Generalized Myasthenia Gravis | Recruiting |
| NCT06149559 | A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe… | Generalized Myasthenia Gravis | Recruiting |
| Phase 2 | |||
| NCT07277660 | A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and… | Atopic Dermatitis | Recruiting |